Elliot Norry
Chief Tech/Sci/R&D Officer chez ADAPTIMMUNE THERAPEUTICS PLC
Fortune : 86 443 $ au 31/03/2024
Profil
Elliot Norry is currently the Chief Medical Officer at Adaptimmune Therapeutics Plc since 2020.
Prior to this, he worked as a Director at Covenant Financial, Inc. Dr. Norry completed his undergraduate degree at Columbia College (MO) and holds a doctorate degree from New York University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/01/2024 | 257 165 ( 0,05% ) | 67 735 $ | 31/03/2024 | |
| 12/01/2024 | 11 841 ( 0,00% ) | 18 709 $ | 31/03/2024 |
Postes actifs de Elliot Norry
| Sociétés | Poste | Début |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Anciens postes connus de Elliot Norry
| Sociétés | Poste | Fin |
|---|---|---|
Covenant Financial, Inc.
 Covenant Financial, Inc. Financial ConglomeratesFinance Covenant Financial, Inc. engages in the provision of commercial banking services. The company was founded in 2015 and is headquartered in Doylestown, PA. | Director/Board Member | - |
Formation de Elliot Norry
| Columbia College (MO) | Undergraduate Degree |
| New York University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Covenant Financial, Inc.
Covenant Financial, Inc. Financial ConglomeratesFinance Covenant Financial, Inc. engages in the provision of commercial banking services. The company was founded in 2015 and is headquartered in Doylestown, PA. | Finance |
